Increased treatment-related toxicity subsequent to an anti-PD-1 agent

被引：5

作者：

Khoja, Leila ^{[1
]}

Butler, Marcus Ortho ^{[1
]}

Chappell, Mary Anne ^{[1
]}

Hogg, David ^{[1
]}

Joshua, Anthony M. ^{[1
]}

机构：

[1] Princess Margaret Canc Ctr, Dept Med Oncol GU Melanoma, Toronto, ON M5G 2M9, Canada

来源：

CURRENT ONCOLOGY | 2015年 / 22卷 / 04期

关键词：

METASTATIC MELANOMA; BRAF INHIBITORS; VEMURAFENIB; IPILIMUMAB; COHORT; TRIAL;

D O I：

10.3747/co.22.2418

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E320 / E322

页数：3

共 12 条

[1]

[Anonymous], ANN ONCOL S5

[2] Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program [J].

Ascierto, Paolo Antonio ;

Simeone, Ester ;

Sileni, Vanna Chiarion ;

Del Vecchio, Michele ;

Marchetti, Paolo ;

Cappellini, Gian Carlo Antonini ;

Ridolfi, Ruggero ;

de Rosa, Francesco ;

Cognetti, Francesco ;

Ferraresi, Virginia ;

Testori, Alessandro ;

Queirolo, Paola ;

Bernengo, Maria Grazia ;

Guida, Michele ;

Galli, Luca ;

Mandala, Mario ;

Cimminiello, Carolina ;

Rinaldi, Gaetana ;

Carnevale-Schianca, Fabrizio ;

Maio, Michele .

CANCER INVESTIGATION, 2014, 32 (04) :144-149

[3] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].

Chapman, Paul B. ;

Hauschild, Axel ;

Robert, Caroline ;

Haanen, John B. ;

Ascierto, Paolo ;

Larkin, James ;

Dummer, Reinhard ;

Garbe, Claus ;

Testori, Alessandro ;

Maio, Michele ;

Hogg, David ;

Lorigan, Paul ;

Lebbe, Celeste ;

Jouary, Thomas ;

Schadendorf, Dirk ;

Ribas, Antoni ;

O'Day, Steven J. ;

Sosman, Jeffrey A. ;

Kirkwood, John M. ;

Eggermont, Alexander M. M. ;

Dreno, Brigitte ;

Nolop, Keith ;

Li, Jiang ;

Nelson, Betty ;

Hou, Jeannie ;

Lee, Richard J. ;

Flaherty, Keith T. ;

McArthur, Grant A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516

[4] Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma [J].

Hamid, Omid ;

Robert, Caroline ;

Daud, Adil ;

Hodi, F. Stephen ;

Hwu, Wen-Jen ;

Kefford, Richard ;

Wolchok, Jedd D. ;

Hersey, Peter ;

Joseph, Richard W. ;

Weber, Jeffrey S. ;

Dronca, Roxana ;

Gangadhar, Tara C. ;

Patnaik, Amita ;

Zarour, Hassane ;

Joshua, Anthony M. ;

Gergich, Kevin ;

Elassaiss-Schaap, Jeroen ;

Algazi, Alain ;

Mateus, Christine ;

Boasberg, Peter ;

Tumeh, Paul C. ;

Chmielowski, Bartosz ;

Ebbinghaus, Scot W. ;

Li, Xiaoyun Nicole ;

Kang, S. Peter ;

Ribas, Antoni .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :134-144

[5] Vemurafenib Sensitivity Skin Reaction after Ipilimumab [J].

Harding, James J. ;

Pulitzer, Melissa ;

Chapman, Paul B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :866-868

[6] Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial [J].

Hauschild, Axel ;

Grob, Jean-Jacques ;

Demidov, Lev V. ;

Jouary, Thomas ;

Gutzmer, Ralf ;

Millward, Michael ;

Rutkowski, Piotr ;

Blank, Christian U. ;

Miller, Wilson H., Jr. ;

Kaempgen, Eckhart ;

Martin-Algarra, Salvador ;

Karaszewska, Boguslawa ;

Mauch, Cornelia ;

Chiarion-Sileni, Vanna ;

Martin, Anne-Marie ;

Swann, Suzanne ;

Haney, Patricia ;

Mirakhur, Beloo ;

Guckert, Mary E. ;

Goodman, Vicki ;

Chapman, Paul B. .

LANCET, 2012, 380 (9839) :358-365

[7] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].

Hodi, F. Stephen ;

O'Day, Steven J. ;

McDermott, David F. ;

Weber, Robert W. ;

Sosman, Jeffrey A. ;

Haanen, John B. ;

Gonzalez, Rene ;

Robert, Caroline ;

Schadendorf, Dirk ;

Hassel, Jessica C. ;

Akerley, Wallace ;

van den Eertwegh, Alfons J. M. ;

Lutzky, Jose ;

Lorigan, Paul ;

Vaubel, Julia M. ;

Linette, Gerald P. ;

Hogg, David ;

Ottensmeier, Christian H. ;

Lebbe, Celeste ;

Peschel, Christian ;

Quirt, Ian ;

Clark, Joseph I. ;

Wolchok, Jedd D. ;

Weber, Jeffrey S. ;

Tian, Jason ;

Yellin, Michael J. ;

Nichol, Geoffrey M. ;

Hoos, Axel ;

Urba, Walter J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723

[8] Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy [J].

Johnson, Douglas B. ;

Wallender, Erika K. ;

Cohen, Daniel N. ;

Likhari, Sunaina S. ;

Zwerner, Jeffrey P. ;

Powers, Jennifer G. ;

Shinn, Lisa ;

Kelley, Mark C. ;

Joseph, Richard W. ;

Sosman, Jeffrey A. .

CANCER IMMUNOLOGY RESEARCH, 2013, 1 (06) :373-377

[9]

ROBERT C, 2015, N ENGL J MED

[10] Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial [J].

Robert, Caroline ;

Ribas, Antoni ;

Wolchok, Jedd D. ;

Hodi, F. Stephen ;

Hamid, Omid ;

Kefford, Richard ;

Weber, Jeffrey S. ;

Joshua, Anthony M. ;

Hwu, Wen-Jen ;

Gangadhar, Tara C. ;

Patnaik, Amita ;

Dronca, Roxana ;

Zarour, Hassane ;

Joseph, Richard W. ;

Boasberg, Peter ;

Chmielowski, Bartosz ;

Mateus, Christine ;

Postow, Michael A. ;

Gergich, Kevin ;

Elassaiss-Schaap, Jeroen ;

Li, Xiaoyun Nicole ;

Iannone, Robert ;

Ebbinghaus, Scot W. ;

Kang, S. Peter ;

Daud, Adil .

LANCET, 2014, 384 (9948) :1109-1117

← 1 2 →